|Description||Nor NOHA monoacetate is a potent, selective, competitive, and high affinity inhibitor of arginase with a Ki value of 0.5 µM, which is 20-fold lower than the Ki of 10 µM observed for NOHA. It enhances the effect of acetylcholine on isolated aortic and mesenteric arterial rings, and inhibits growth of lung carcinoma implants in mice.|
|Related CAS||189302-40-7 (free base); 291758-32-2 (HCl)|
|Synonyms||(2S)-2-Amino-4-[[(hydroxyamino)iminomethyl]amino]butanoic acid monoacetate; Nω-hydroxy-nor-Arginine|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
Arbidol is an antiviral agent using for the treatment of influenza infection in Russia and China. It inhibits membrane fusion and prevents contact between the v...
ML192 is a selective ligands for GPR55 with 1080 nM potency for GPR55 and >45-fold antagonist and agonist selectivity against GPR35, CB1 and CB2.
BAY-876 is a potent and selective GLUT1 inhibitor (IC50 = 2 nM) with good stability in vitro and high bioavailability in vivo. BAY-876 can be used as an antican...
Netupitant N-Oxide is a derivative of Netupitant which is a potent and selective neurokinin-1 receptor (NK1) receptor antagonist. It is achiral and orally activ...
AD80, also called as A-196, is a multikinase inhibitor that inhibits against human BRAF, S6K, and SRC and shows strong activity against RET inhibitor.
A selective COX-2 inhibitor; GPR35 activator; Cox-2: IC50 = 918 nM (human); Cox-1: IC50 = 1.06 µM (human); GPR35: IC50 = 1.28 µM (human)
(-)-p-Bromotetramisole Oxalate is a potent and non-specific alkaline phosphatase inhibitor.
OGT 2115 is a heparanase inhibitor with IC50 value of 0.4 μM. It shows antiangiogenic properties in vitro.